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Abstract
Telocytes (TCs) are a newly discovered type of cell with numerous functions. They have been found in a large variety of organs: heart (endo-,
myo-, epi- and pericardium, myocardial sleeves, heart valves); digestive tract and annex glands (oesophagus, stomach, duodenum, jejunum,
liver, gallbladder, salivary gland, exocrine pancreas); respiratory system (trachea and lungs); urinary system (kidney, renal pelvis, ureters, blad-
der, urethra); female reproductive system (uterus, Fallopian tube, placenta, mammary gland); vasculature (blood vessels, thoracic duct); serous
membranes (mesentery and pleura); and other organs (skeletal muscle, meninges and choroid plexus, neuromuscular spindles, fascia lata,
skin, eye, prostate, bone marrow). Likewise, TCs are widely distributed in vertebrates (fish, reptiles, birds, mammals, including human). This
review summarizes particular features of TCs in the female reproductive system, emphasizing their involvement in physiological and pathophys-
iological processes.
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History
Telocytes (TCs) were discovered in 2005 when L.M. Popescu’s group
from Bucharest, Romania, described a new type of cell that resides in
the stroma of several organs, which became known as interstitial
Cajal-like cells (ICLC). This group named these cells as ICLC because
of their apparent similarity with the canonical gastrointestinal cells of
Cajal (ICC), the gut pacemaker cells. A few years later, in 2008, M.S.
Faussone-Pellegrini and her team from Florence, Italy, described ICLC
in the muscle coat of the human gut and noticed they consistently dif-
fered from the ICC in both ultrastructure and immunophenotype. In
2010, after confirming the presence of this particular cell type in the
stroma of many organs and characterized it by immunohistochem-
istry and electron microscopy, the two groups agreed they were
describing a ‘novel’ cell type and that the name ICLC should be chan-
ged to a more appropriate one. From then on, this novel cell type
became known as the TCs (using the Greek affix ‘Telos’) [1, 2].
Characteristics of telocytes
(morphology, contacts)
Telocytes have been shown to differ from fibroblasts and mesenchy-
mal stem cells in terms of gene profile and proteomics, and in micro-
RNA expression. They have the principal morphological
characteristics contrasted with other types of cells [3]. Currently, the
most demonstrative and widespread methods for identification of TCs
include transmission electron microscopy (TEM), immunohistochem-
istry and immunofluorescence. Transmission electron microscopy is
considered the most accurate method for identifying TCs [4].
The TC has a small, oval-shaped cellular body, containing a
nucleus, surrounded by a small amount of cytoplasm. The cellular
body average dimensions are, as measured on TEM images,
9.39 lm  3.26 lm (min = 6.31 lm; max = 16.42 lm). The
nucleus occupies about 25% of the cell volume and contains clusters
of heterochromatin attached to the nuclear envelope.
The perinuclear cytoplasm is rich in mitochondria (which occupy
about 5% of the cell body) particularly in podoms, which contain a
*Correspondence to: Krzysztof GIL, M.D., Ph.D.
E-mail: mpgil@cyf-kr.edu.pl
ª 2016 The Authors.
Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use,
distribution and reproduction in any medium, provided the original work is properly cited.
doi: 10.1111/jcmm.12843
J. Cell. Mol. Med. Vol 20, No 6, 2016 pp. 994-1000
small Golgi complex, as well as the elements of rough and smooth
endoplasmic reticulum and cytoskeletal elements (thin and intermedi-
ate filaments) [5–7].
The cell periphery is represented by the usual plasmalema, with
no (or thin and discontinuous) basal lamina, and some caveolae
(about 2–3% of cytoplasmatic volume; ~0.5 caveolae/lm of cell
membrane length).
The shape of the TCs depends on the number of their telopodes
Tps: piriform for one prolongation, spindle for two Tps, triangular for
three, stellate, etc. Their spatial appearance is that of a polyhedron with
a different number of vertices, depending on their TP number [1, 2, 7].
Telocytes have a variable number of Tps (very long cellular exten-
sions), which are probably the longest cellular prolongations in the
human body. Tps are made by an alternation of dilated portions,
named podoms (250–300 nm), containing mitochondria and endo-
plasmic reticulum and podomers (~80 nm) with thin segments. The
main characteristics of Tps:
1 Number: 1–5, frequently only 2–3 Tps are observed on a
single section, depending on site and angle of section, since
their 3D convolutions impede their observation in a very thin
2D section along the entire length of the TP their full length.
2 Length: from tens to hundreds of lm, as measured on EM
images. However, under favourable condition in cell cultures,
their entire length can be captured.
3 Thickness: an uneven caliber, mostly below 0.2 lm (resolving
power of light microscopy), visible under electron microscopy,
only 0.10 lm  0.05 lm (min = 0.03 lm; max = 0.24 lm)
4 Moniliform aspect, with many dilations along their length;
5 Presence of ‘Ca2+-release units’ at the level of the dilations,
accommodating mitochondria, elements of endoplasmic reticu-
lum and caveolae;
6 Branching, with a dichotomous pattern;
7 Organization in a network—forming a labyrinthine system by
tridimensional convolution and overlapping, communicating
through gap junctions.
These characteristic features make Tps clearly different from neu-
ronal dendrites, the processes of antigen-presenting dendritic cells or
fibroblasts and myofibroblasts [2, 8].
In uterine tissue, TCs can influence contractile activity of smooth
muscle cells. They differed with pregnant states in telopodal width
and podomic thickness, which can be considered to be related to their
function [9, 10]. Current studies showed the podomers are thicker in
nonpregnant myometrium than in pregnant (~82 versus 75 nm), and
the podoms were thicker in pregnant myometrium (~316 versus
269 nm) [4, 6].
Popescu and Enciu experimentally demonstrated that TCs mor-
phology changes with ageing and by modifying the redox balance of
the cell culture environment. Oxidative stress impairs the ability of
TCs to form Tps and lessens the migration pathway length. Ageing
further aggravated this effect [11].
Furthermore, TCs demonstrate specific direct (homocellular and
heterocellular junctions) and/or indirect (chemical, paracrine/jux-
tacrine signalling, microvesicles and exosomes, sex hormone and
microRNAs) contacts with various surrounding cells [1, 7, 8].
Telopodes are connected to each other by homocellular junctions
and appear to form a 3D network in the interstitial space at the border
of smooth muscle cell bundles. They also contain cytoskeleton ele-
ments. Connections between TCs-exosomes-intercellular junctions-
cytoskeleton form the equivalent of a primitive nervous system [9,
10, 12, 13].
Heterocellular nanocontacts1 were frequently described between
TCs and myocytes, or TCs and immune cells. Their contacts with
mast cells provide a reason to predict their participation in immunore-
actions (mastocytes-mediated immunoregulation/and immunosurveil-
lance). Moreover, various studies have revealed that this class of
cells play two roles in the immune response. During the physical pro-
cess, TCs can be activated to maintain homeostasis to induce prolifer-
ation, differentiation and tissue regeneration. On the other hand, they
initiate tissue inflammation to induce pathogenesis under some
challenges [14].
Telocytes also surrounded stem cell niches with Tps and hetero-
cellular contacts. In addition, they establish physical contacts with
nerve endings, blood vessels and different types of progenitor cells.
Accumulating studies have shown that TCs play an indisputable role
in neo-angiogenesis. As TCs have cytoskeleton elements (myosin-14,
periplakin), this predicts that they could be responsible for detecting
smooth muscle cell stretch during the enlargement of the uterus in
pregnancy [6, 13, 15, 16].
Telocytes release at least three types of extracellular vesi-
cles: exosomes (45  8 nm), ectosomes (128  28 nm) and
multivesicular cargos (1  0.4 lm) from their Tps and, occa-
sionally, from the cell body [4]. Specifically, extracellular vesi-
cles and/or exosomes are shed or released from Tps in
uterine TCs. Mediators, such as interleukin (IL)-6, VEGF and
nitric oxide, are secreted from TCs. Growth factors, including
IL-6, VEGF, macrophage inflammatory protein 1a, macrophage
inflammatory protein-2 and monocyte chemoattractant protein
1, are significantly expressed along with additional cytokines,
including IL-2, IL-10, IL-13 and chemokines, such as growth-
related oncogene/keratinocyte-derived chemokine in the secre-
tome of cultured rodent cardiac TCs [17]. Besides, in a renal
ischaemia-inflammatory injury model, TCs activated the nuclear
factor kappa B signalling pathway and upregulated the mRNA
levels of pro-inflammatory cytokines such as IL-1 and tumour
necrosis factor-a [17, 18].
1Nanocontacts—heterocellular communications between TCs and car-
diomyocytes, which do not belong to classic types of junctions found in
textbooks. It has no typical features for different types of junctions known,
except small nanopillars (10–15 nm/20–30 nm) that connect the cellular
membranes. The bridging structure suggests a molecular interaction
between the Tps and cardiomyocytes but their electron density is below
the density of membranes, and isosurface reconstruction is not appropri-
ate to imagine these nanostructures. Different sections through the recon-
structed volume showed clusters of nanocontacts with symmetrical
distribution, fastening the connection between TCs and cardiomyocytes.
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Gene expression profile of telocytes
Nowadays, increasing knowledge in the chromosomal gene expres-
sion profile of TCs can be a further step in research. Several studies
have shown interconnections between TCs and genes of chromo-
somes 1, 2, 3, 4, 17 and 18. Three genes, Capn2, Fhl2 and Qsox1,
were overexpressed in pulmonary TCs compared with the other cells.
TCs enriched with Capn2 and Fhl2 may be associated with the regula-
tion of tissue inflammation, injury, repair, immune responses or cell
movement. Besides, as Capn2 is important for embryogenesis, it
explains the involvement of TCs in morphogenesis and tissue home-
ostasis. The lower expression of chromosome 1 genes in TCs, as
compared with other cells, was found for Ifi203 (interferon-activated
gene 203) and Tcea1 (transcription elongation factor A SII-1) [11, 19].
In chromosome 2, 26 genes were overexpressed in TCs. One gene
Myl9 (myosin, light polypeptide 9) was overexpressed most in TCs,
different from other cells. Myl9 regulatory gene encodes the regula-
tory light chains of myosin II molecule, known to play a central role in
cell adhesion, migration and division. There were six genes, e.g. Pltp,
Gzf1, Polr1b, Tasp1, Zbtb34 and Zfp120, down-expressed most in
TCs, differentially from other cells. In chromosome 3, there were 13
up- and 59 down-regulated genes in TCs [20].
Approximately 15% and 12% genes in chromosomes 17 and 18
were identified as TCs-specific genes. Sixteen and 10 of TCs-specific
genes were up-regulated, and 68 and 22 were down-regulated in
chromosome 17 and 18, as compared with other cells. Most of the
observed genes in both chromosomes were immune-associated,
which supported the role of TCs in immune surveillance and immune
homeostasis [14].
In chromosome 4, 17 genes were up- and 56 down-regulated.
Among up-regulated genes were Akap2, Gpr153, Sdc3, Tbc1d2,
which encode proteins involved in cell signalling pathways and
cytoskeleton organization. It seems that TCs could integrate signals




As any type of cells, TCs have own immunohistochemical profile. Cur-
rent studies demonstrate expressions or (co-) expression of different
markers in TCs, which at the same time not are peculiar to a given
organ. TCs are immunohistochemically positive for CD34 (Table 1),
CD117/c-Kit, plated-derived growth factor receptor alpha and beta
(PDGFRa and-b), VEGF, inducible nitric oxide synthase (iNOS), calve-
olin-1, vimentin, connexin 43, oestrogen and progesterone receptors
(PRs), CD44, desmin, nestin and cadherin-11, according to the TC
location. In addition, they are immunohistochemically negative for
procollagen 1, CD31/PECAM-1 (endothelial cells), a-smooth muscle
actin (a-SMA) (myofibroblasts, pericytes, and vascular SMCs),
CD11c (dendritic cells and macrophages), CD90/Thy-1 (fibroblasts)
and, sometimes, c- kit/CD117 (mast cells). For instance, Tps of TCs
from non-pregnant myometrium are intensively positive for vimentin,
a cytoskeleton protein [6, 9, 22–27]. Telocytes are also negative for
CD68 and other markers associated with immune functions (CD1a,
CD62-P), suggesting a clear difference between TCs and macro-
phages. However, hypothetically TCs, myocytes and leucocytes could
work together in pregnancy maintenance or in the onset of labour [6].
It is important to note that TCs might have subpopulations. The
expression of c-kit receptors differs between TCs populations (possi-
ble site dependant). For instance, rat uterus tissue contains different
types of immune positive TCs: c-kit ()/vimentin (+), c-kit (+)/vi-
mentin (+), c-kit (+)/CD34 (+). This range might be basis of region-
specific TCs roles [13].
Table 1 Panel of primary antibodies for detecting CD34 in telocytes
Type of tissue Antibody Clone Name of company Dilution Time
Human myometrium Monoclonal mouse CD34 8G12 BD Immunocytometry Systems,
San Jose, CA, USA
1:10 4 hrs, RT
Human myometrium Goat anti-CD34 R&D, Minneapolis, MN, USA 1:20 2 hrs, RT
Human myometrium Goat polyclonal CD34 sc-7045 Santa Cruz Biotechnoogy, Inc.,
Heidelberg, Germany
1:50 1 hr, RT
Human placenta Monoclonal mouse
anti-human CD34
QBEnd-10 Cat. No. M7165; Dako,
Glostrup, Denmark
1:25 1 hr, RT
Human placenta Mouse CD34 563 Cat. No. 550760; BD Biosciences 1:50 1 hr, RT
Human myometrium Monoclonal mouse
anti-human CD34
QBEnd-10 Cat. No. M7165; Dako 1:100 30 min., RT
1:50 1 hr, RT
Human bladder Monoclonal mouse
anti-human CD34
Cat. No. M7165; Dako 1:50 Overnight, RT
RT: room temperature.
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In the chorial villi, some TCs are c-kit-positive; and some CD34
positive A of the CD34 positive TC express vimentin and calveolin-1,
and some of them also c-kit. In cultured cells from the same placental
villi, some TCs are double positive for c-kit and iNOS and others for
c-kit and VEGF [26].
Electrophysiology
Telocytes are also involved in the electrical modulation of excitable tis-
sue, such as the smooth muscle of the gut and uterus. They can sponta-
neously initiate electrical activity and modulate of glandular and immune
activity [28]. Ion channels, such as T-type calcium and small-conduc-
tance calcium-activated potassium channels, are present in TCs [7].
T-type calcium channels are present in TCs from human myome-
trium, which, in pregnancy and labour, could participate in the gener-
ation of endogenous bioelectric signals responsible for the regulation
of the surrounding cell behaviour. Surprisingly, this might be the
missing link for describing the molecular mechanisms by which TCs
are involved in mechanical stretching during uterine enlargement in
pregnancy. The expression of a-subunit of T-type calcium channels in
TCs is less intense in the case of non-pregnant myometrium [22].
Steroid hormones and oxytocin might mediate the higher expres-
sion of T-type calcium channels in TCs derived from pregnant myo-
metrium. As TCs have steroid hormone receptors, this might lead to
frequent and sustained contractions able to trigger birth [29].
There is the opposite situation in the expression of small-conduc-
tance calcium-activated potassium channels isoform 3 (SK3). This type
of ion channel has been identified in the myometrium of several species
including human, mice and rats, but with great interspecies variation in
the pattern of expression and regulation [30]. The SK3 channels have
been detected more often in non-pregnant myometrium, whiereas preg-
nant myometrium showed a lack of them. A similar situation with SK3
expression in vascular endothelium is found during pregnancy. These
are also expressed in TCs and are down-regulated during pregnancy
when they reduce contractility [28]. Telocytes may represent a novel
mechanism controlling the excitability of the uterine musculature. As has
been suggested by Cretoiu et al. and Allix et al., a possible mechanism
could be via a tyrosine-kinase independent signalling pathway [23, 31].
In the myometrium, TCs contain only outward potassium-rectifier
channels, but no inward currents have been evidence so far. There
also is a lack of regular slow waves of depolarization in TCs from
myometrium.
Laser-stimulation of telocytes
The low-level laser stimulation (LLLS) of TCs produces a higher
growth rate of lateral telopodal extension in pregnant myometrium
primary cultures as compared to non-pregnant ones. The angel of
deviation is more accentuated in TCs from human pregnant myome-
trium than in TCs from non-pregnant myometrium. Therefore, some
implications are emerging for low-level laser therapy in uterine regen-
erative medicine. Telopodes from the pregnant uterus are more prone
to extend upon LLLS compared to those from the non-pregnant
uterus. The required number of stimulations is sometimes three times
higher than in pregnant myometrium. In both preparations, Tps seem
to accumulate a big part of their resources near the stimulation area.
Finger-like structures were probed with the laser beam. In some
experiments, the TP appears to be is breaking off its old connection,
maintaining only thin ‘anchors’ beyond the point of stimulation.
Twenty-five percent of TCs from pregnant uterus present a local
thickening of the TP upon LLLS. The local thickening phenomenon was
directly correlated with a delayed telopodal response to stimulation [9].
Some experiments have been carried out on the action of imatinib
(c-kit receptor antagonist) on the spontaneous and oxytocin-induced
contractions in human non-pregnant myometrium and the myome-
trium of pregnant rabbits. C-kit inhibition led to a reduction in both
the amplitude and frequency of myometrial contraction in a dose-
dependent manner. Results show that TCs might be players in the
coordination of uterine activity in a kit-independent manner. This may
be under hormonal influences, since express oestrogen and PRs. Also
TCs could be modulators of the electrical excitability of underlying
contractions, but are not necessarily pacemakers [6, 23, 32].
Characteristics of TCs in pregnant/
non-pregnant condition
Numerous experiments have shown that the amount of TCs in endo-
metrium and myometrium in rats changes depending on its reproduc-
tive state. In pregnant uteri endometrial TCs increase, compared with
non-pregnant, in spite of a significant decline in the number of
myometrial TCs. Postpartum uteri show the highest significant count
of myometrial TCs and non-significant difference in endometrial TC
count, as compared with the adult non-pregnant group. The lowest
count of both types of TCs occurs in the immature rat uteri, whereas
the highest amount of endometrial TCs was detected in the pregnant
uteri and the highest amount of myometrial TCs in the postpartum
uteri. Telocytes produce electric slow waves that trigger and coordi-
nate smooth muscle contractions; the decrease in myometrial TCs
numbers in the pregnant rat uterus may explain the prevention of pre-
term delivery (uterine contractility before term). The increase after
delivery may be connected with the involution of the uterus accompa-
nied by myometrial contractions [33].
In one further example of involving TCs in pregnancy is their
increase during that condition. Hence, Hatta et al. has suggested that
TCs are frequently present in tissues that have a low cell density and
significant space between neighbouring cells. Moreover, TCs express
connexin 43, a gap junction protein, which most likely has a vital role
in decidual maturation, as its decrease is associated with recurrent
pregnancy loss [4, 34].
In a literature study, we have estimated the average number of
TCs in human uterus. Telocytes constituted about 7% of the total cell
number in non-pregnant myometrial cell culture and about 3% of the
entire cell population in the myometrium of adult non-pregnant
humans [33]. This was not accompanied by any difference in the
size of TC’s exo- and ectosomes in pregnant and non-pregnant
myometrium [4].
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In addition, the number of CD117-positive cells is reduced during
pregnancy under normal condition. This prevents myogenic contrac-
tions and early delivery, as CD-117-positive cells within the myome-
trium are involved in myogenic contractile mechanisms during
pregnancy [32].
A study on the role of murine TCs pregnancy-induced liver growth
demonstrated the potential involvements of TCs in hepatic prolifera-
tive adaptations to pregnancy. An increase in CD34/PDGFR-a positive
TCs in pregnant liver accompanied by high level of hepatocyte prolif-
eration [35].
Main features of TCs in endometrium
and Fallopian tubes
In the human endometrium, the location of TCs is contoured to the
shape of the adjacent epithelial architecture. They may support the
structure of the gland and nearby stroma as a functional unit by form-
ing a scaffold around them. In addition, they may take part in loosen-
ing the matrix or secreting factors during decidual formation [34].
Telocytes, which were observed from rat’s endometrium, stained pos-
itive for connexin 43, a protein involved in gap junctions. Connexin 43 is
involved in maturation of decidua and its decreasing connection with
recurrent pregnancy loss. Endometrial TCs may play the role of gap junc-
tions and have impact on normal developing of pregnancy [33].
In the human Fallopian tube, TCs are located mainly in
mucosa and muscular layer among smooth muscle fibres [36].
Oviduct TCs numbers decline in women with endometriosis, tubal
ectopic pregnancy and acute salpingitis. Probably, this can be
caused by the overproduction of iNOS, COX-2, LPO and estradiol
in oviduct tissue, and TCs damage results. In acute salpingitis-
affected oviduct tissues, TCs levels were greatly decreased or
even completely lost. They are severely damaged/degenerated
with multiple ultrastructural abnormalities, such as loss of orga-
nelles, numerous swollen nuclei, mitochondrial and rough endo-
plasmic reticulum dilatation, cytoplasmic vacuolization,
discontinuation or dissolution of Tps and swollen or loss of
intercellular junctions as Tps and activated immunocyte (eosino-
philes) with dense secretory granules respectively [37].
Damage and loss of TCs can change the activity of TCs-stem cells
and decrease tissue reparation or renewal capacity, subsequently
inducing the development of tissue fibrosis within endometriosis-
affected oviduct. This will then cause Fallopian tube dysfunction and
infertility. On the other hand, the reconstruction TCs network might
be of great value for structural and functional reparation of fibrous
disease of Fallopian tube [13, 25].
In addition, oviduct TCs express oestrogen receptor alpha and
PR-A, and thus might act as ‘hormonal sensors’, and their function
may be in part under hormonal control. These receptors are specific
for TCs localization. For example, TCs of gallbladder are negative for
both types of receptors and gallbladder muscular contractions are not
regulated by sex steroids. TCs were more often tested with anti PR-A
antibody. The PR-A expression is recognized by most anti-PR anti-
bodies, whereas the PR-B expression was not detected. It is possible
that sex steroid levels could impact on TCs via connexin43-mediated
mechanism [38].
TCs in human placenta
The placenta also contains functional TCs. They were discovered in
the large stem villi, with their long, slender process surrounding the
blood vessel wall, or interposed between arterioles and the tro-
phoblast basement membrane in small stem villi. The TCs were con-
nected by gap junctions in a network extending into the placental
stroma between concentric layers formed by smooth muscle cells
and myofibroblasts around large blood vessels. The TCs had close
contacts with mast cells, Hofbauer cells,2 myofibroblasts and smooth
muscle cells. Moreover, they have close contacts with different
perivascular smooth muscle cells through different branches [26,
39].
In addition, TCs in human term placenta are positive for c-kit,
CD34, vimentin, caveolin-1, VEGF and iNOS. Presumptive roles of
TCs in term placenta are partly related to their immunologic profile.
Firstly, as TCs are located near vessels and, as the placenta is a non-
innervated organ, they might be involved in blood flow regulation.
Secondly, TCs express VEGF and might have impact on tissue remod-
elling. Finally, TCs appear frequently cited as an ‘intercellular bridge’
between two HBCs. They might play the role of immune surveillance.
Moreover, TCs express steroid hormone receptors. This could have
an impact on the development of connections between the placenta
and uterus [26, 40].
Telocytes are identified close to small vessels and express angio-
genesis-related factors (VEGF, nitric oxide) and pro-angiogenic
microRNAs (miR126, miR130a, let-7-family, miR-10, miR-155 and
miR-503). Moreover, it has been shown that CD34 positive cells
secrete vesicles (exosomes) that have an independent angiogenic
activity, both in vitro and in vivo [41, 42]. Likewise, TCs have been
shown to express significant amounts of miR-21, -22, -29, and -199a
and oestrogen and PRs. Micro-RNA can be involved in the pathogene-
sis of uterine leiomyomata, as had been proved by current genetic
research. Consequently, TCs may have a significant impact on uterine
leiomyoma formation [4, 43, 44].
Possible role of TCs in female
reproductive system
Numerous studies have been carried out in order to detect the proper-
ties and functions of TCs in female reproductive organs over the past
10 years. Apparently, these new cells play significant roles in normal
physiological processes (and their pathologies) like myometrial con-
tractility, immune responses, the development and secretions of the
2Hofbauer cells (HBCs) are placental macrophages that are present in the
villus across gestation. Despite their identification more than 100 years
ago, their specific role in placental function remains largely unelucidated.
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placenta, regulation of adaptive response to overcome vascular resis-
tance during normal pregnancy.
The list also includes the role of TCs on angiogenesis and tissue
development, which can be crucial in cancerogenesis, uterine leiomy-
oma formation, ectopic tubal pregnancy, endometriosis and salpingitis.
Telocytes are located in the neuromuscular spindles and partici-
pate in the control of muscle tone and motor activity. Telocytes form
homo- and heterocellular contacts with adjacent cells and might even
be able to control and regulate their activity, participating in tissue
remodelling/renewal [6]. An immune surveillance role was suggested
for the network of TCs, located in human Fallopian tube [1]. Tubal
TCs were reported to be involved in the early onset of endometriosis
and acute salpingitis [37]. Moreover, the decrease in TCS caused dys-
regulation of oviduct motility, suggesting that tubal TCs impairment
leads to the infertility of the tubal origin and even tubal ectopic
pregnancy [13].
Telocytes could serve as the ‘hormonal sensors’ in human uterus,
since there is an evidence of some uterine stromal cells that play a
role in endometrial growth and differentiation in a hormone-depen-
dent manner [6]. They also contribute to cell migration and prolifera-
tion of myometrial tissue [7]. Thus, TCs may also be involved in the
hyperplasia of endometrium.
Telocytes, myocytes and leucocytes could work together in
pregnancy myometrium or in the onset of labour [6]. They even
might play a role in preventing premature uterine contractility
[7].
Genetic and immunologic profiles of TCs give us an opportunity
to explore its cooperation with immune cells. Applications in regener-
ative medicine may extend the therapeutic role of TCs in pathological
conditions. We are only at the beginning of our explorations of the
powers and the versatility of TCs.
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